BI 1356 BS

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for BI 1356 BS, covering 2014-07-08 to 2017-12-28. Get the full timeline:

Most recent: Clinical Trial Update: BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus [Phase 2]